Stay updated on Arbaclofen in Children and Adolescents With ASD Clinical Trial
Sign up to get notified when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.

Latest updates to the Arbaclofen in Children and Adolescents With ASD Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a 403 Forbidden error with minimal navigation (e.g., Home and Revision information), replacing the previous detailed study content and related metadata.SummaryDifference21%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a new revision tag, v3.6.6, replacing the previous v3.6.5, representing a minor internal update to the study details page.SummaryDifference0.0%

- Check30 days agoChange DetectedA note indicating NIH funding for 2018 was added, reflecting NIH support for the study.SummaryDifference0.0%

- Check44 days agoChange DetectedA new site entry, Hospital General Universitario Gregorio Marañon, was added to the study locations (non-accented form) and the accented version Hospital General Universitario Gregorio Marañón was removed. The revision tag was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating an internal update to the page. There are no changes to the study content or user-facing information.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page’s revision history now shows a new revision label v3.6.3, replacing the previous v3.6.2. This reflects a minor update to the page’s metadata.SummaryDifference0.0%

Stay in the know with updates to Arbaclofen in Children and Adolescents With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.